HIV-DRIVES: HIV drug resistance identification, variant evaluation, and surveillance pipeline
Authors:
- Stephen KanyereziSKStephen Kanyerezi
- Ivan SserwaddaISIvan Sserwadda
- Aloysious SsemagandaASAloysious Ssemaganda
- Julius SeruyangeJulius Seruyange
- Alisen AyitewalaAAAlisen Ayitewala
- Hellen Rosette OundoHOHellen Rosette Oundo
- Wilson TenywaWTWilson Tenywa
- Brian A. KagurusiBKBrian A. Kagurusi
- Godwin TusabeGTGodwin Tusabe
- Stacy WereSWStacy Were
- Isaac SsewanyanaISIsaac Ssewanyana
- Susan NabaddaSNSusan Nabadda
Open Access
- 1 July 2024
- journal article
- research article
- Published by Microbiology Society in Access Microbiology
- Vol. 6 (7) , 000815.v3
Abstract
The global prevalence of resistance to antiviral drugs combined with antiretroviral therapy (cART) emphasizes the need for continuous monitoring to better understand the dynamics of drug-resistant mutations to guide treatment optimization and patient management as well as check the spread of resistant viral strains. We have recently integrated next-generation sequencing (NGS) into routine HIV drug resistance (HIVDR) monitoring, with key challenges in the bioinformatic analysis and interpretation of the complex data generated, while ensuring data security and privacy for patient information. To address these challenges, here we present HIV-DRIVES (HIV Drug Resistance Identification, Variant Evaluation, and Surveillance), an NGS-HIVDR bioinformatics pipeline that has been developed and validated using Illumina short reads, FASTA, and Sanger ab1.seq files.Keywords
All Related Versions
Funding Information
- PHA4GE (INV-038071)
- CAGE-TB Project
- Foundation for the National Institutes of Health (U2RTW012116)
- Foundation for the National Institutes of Health (U2RTW010672)
- EDCTP (TMA2020CDF-3159)
- African Doctoral Dissertation Research Fellowship
- Eastern Africa Network of Bioinformatics Training (EANBiT) project
This publication has 11 references indexed in Scilit:
- Next-generation sequencing (NGS) reveals low-abundance HIV-1 drug resistance mutations among patients experiencing virological failure at the time of therapy switching in UgandaF1000Research, 2022
- rMAP: the Rapid Microbial Analysis Pipeline for ESKAPE bacterial group whole-genome sequence dataMicrobial Genomics, 2021
- Twelve years of SAMtools and BCFtoolsGigaScience, 2021
- quasitools: A Collection of Tools for Viral Quasispecies AnalysisbioRxiv, 2019
- sierra-local: A lightweight standalone application for drug resistance predictionJournal of Open Source Software, 2019
- HIV-1 Drug Resistance Mutations: Potential Applications for Point-of-Care Genotypic Resistance TestingPLOS ONE, 2015
- Automating HIV Drug Resistance Genotyping with RECall, a Freely Accessible Sequence Analysis ToolJournal of Clinical Microbiology, 2012
- Fast gapped-read alignment with Bowtie 2Nature Methods, 2012
- Rationale and Uses of a Public HIV Drug‐Resistance DatabaseThe Journal of Infectious Diseases, 2006
- Human immunodeficiency virus reverse transcriptase and protease sequence databaseNucleic Acids Research, 2003